Search research articles
Contact Us
Filters
Showing results (31-40 of 228) with videos related to
Page
of 23
Sort By:
Biochemistry
|
July 1, 1986
Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase
J L Krstenansky, D Trivedi, V J Hruby
Journal of Clinical Medicine
|
February 10, 2024
From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
Iyiad Alabdul Razzak, Mazen Noureddin, Hirsh D Trivedi
Applied Biochemistry and Biotechnology
|
March 7, 2014
Kinetic and spectroscopic characterization of 1-naphthol 2-hydroxylase from Pseudomonas sp. strain C5
Vikas D Trivedi, Prabin Majhi, Prashant S Phale
Annals of Hepatology
|
April 12, 2021
Reply to: The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
Hirsh D Trivedi, Michael P Curry, Michelle Lai
Health Services Research
|
June 25, 2020
Discharge against medical advice among neurological patients: Characteristics and outcomes
Aishwarya Raja, Parth D Trivedi, Mandip S Dhamoon
The American Journal of Medicine
|
September 15, 2020
The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
Amr Dokmak, Blanca Lizaola-Mayo, Hirsh D Trivedi
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 13, 2019
Bone Health in Patients With Liver Diseases
Christopher J Danford, Hirsh D Trivedi, Alan Bonder
The American Journal of Medicine
|
February 19, 2021
Infections in Cirrhosis: A Guide for the Clinician
Kirsti A Campbell, Hirsh D Trivedi, Sanjiv Chopra
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 26, 2018
Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation
Guillermo A Ortiz, Hirsh D Trivedi, Claudia Nader
Life Sciences
|
September 26, 1983
Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system
J T Pelton, D Trivedi, V J Hruby
Page
of 23
Search research articles
Search
Showing results (31-40 of 228) with videos related to
Sort By:
Page
of 23
Biochemistry
|
July 1, 1986
Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase
J L Krstenansky, D Trivedi, V J Hruby
Journal of Clinical Medicine
|
February 10, 2024
From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
Iyiad Alabdul Razzak, Mazen Noureddin, Hirsh D Trivedi
Applied Biochemistry and Biotechnology
|
March 7, 2014
Kinetic and spectroscopic characterization of 1-naphthol 2-hydroxylase from Pseudomonas sp. strain C5
Vikas D Trivedi, Prabin Majhi, Prashant S Phale
Annals of Hepatology
|
April 12, 2021
Reply to: The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
Hirsh D Trivedi, Michael P Curry, Michelle Lai
Health Services Research
|
June 25, 2020
Discharge against medical advice among neurological patients: Characteristics and outcomes
Aishwarya Raja, Parth D Trivedi, Mandip S Dhamoon
The American Journal of Medicine
|
September 15, 2020
The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
Amr Dokmak, Blanca Lizaola-Mayo, Hirsh D Trivedi
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 13, 2019
Bone Health in Patients With Liver Diseases
Christopher J Danford, Hirsh D Trivedi, Alan Bonder
The American Journal of Medicine
|
February 19, 2021
Infections in Cirrhosis: A Guide for the Clinician
Kirsti A Campbell, Hirsh D Trivedi, Sanjiv Chopra
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 26, 2018
Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation
Guillermo A Ortiz, Hirsh D Trivedi, Claudia Nader
Life Sciences
|
September 26, 1983
Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system
J T Pelton, D Trivedi, V J Hruby
Page
of 23